Draper has expanded its footprint in the life sciences by agreeing to apply its engineering services and portfolio of cell bioprocessing technologies in a collaboration with Kite, a Gilead Company, designed to enhance Kite’s development of pipeline cell therapies . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge